A Global Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Study Comparing the Analgesic Efficacy and Safety of ABT-652 to Placebo in Subjects With Osteoarthritis Pain of the Knee.
Phase of Trial: Phase II
Latest Information Update: 04 Jan 2013
At a glance
- Drugs ABT 652 (Primary) ; Naproxen
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 11 May 2012 Additional location (USA) added as reported by ClinicalTrials.gov.
- 07 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Apr 2011 Planned end date changed from 1 Oct 2011 to 1 May 2011 as reported by ClinicalTrials.gov